MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 168-174

  Li, Qiang ^a   Zou, Chaoxia ^a   Zou, Chendan ^a   Han, Zhongjing ^a   Xiao, Haifeng ^a   Wei, Huiyan ^a   Wang, Wei ^a   Zhang, Lei ^a   Zhang, Xueying ^a   Tang, Qingchao ^a   Zhang, Chunjing ^b   Tao, Ji ^a   Wang, Xishan ^a   Gao, Xu ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Colon cancer; MicroRNA 25; Migration; Proliferation; Smad7

Indexed keywords

MICRORNA; MICRORNA 25; SMAD7 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; TUMOR XENOGRAFT; VALIDATION STUDY;

3' UNTRANSLATED REGIONS; AGED; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL MOVEMENT; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; SMAD7 PROTEIN; TUMOR BURDEN;

EID: 84878462227     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.029     Document Type: Article

References (30)

1. Ambs S., Prueitt R.L., Yi M., Hudson R.S., Howe T.M., Petrocca F., Wallace T.A., Liu C.G., Volinia S., Calin G.A., Yfantis H.G., Stephens R.M., Croce C.M. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008, 68:6162-6170.
2. Anton R., Chatterjee S.S., Simundza J., Cowin P., Dasgupta R. A systematic screen for micro-RNAs regulating the canonical Wnt pathway. PLoS One 2011, 6:e26257.
3. Arndt G.M., Dossey L., Cullen L.M., Lai A., Druker R., Eisbacher M., Zhang C., Tran N., Fan H., Retzlaff K., Bittner A., Raponi M. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009, 9:374.
4. Baffa R., Fassan M., Volinia S., O'Hara B., Liu C.G., Palazzo J.P., Gardiman M., Rugge M., Gomella L.G., Croce C.M., Rosenberg A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol. 2009, 219:214-221.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Bartels C.L., Tsongalis G.J. MicroRNAs: novel biomarkers for human cancer. Clin. Chem. 2009, 55:623-631.
7. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
8. Esposito F., Tornincasa M., Pallante P., Federico A., Borbone E., Pierantoni G.M., Fusco A. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J. Clin. Endocrinol. Metab. 2012, 97:E710-718.
9. Halder S.K., Rachakonda G., Deane N.G., Datta P.K. Smad7 induces hepatic metastasis in colorectal cancer. Br. J. Cancer 2008, 99:957-965.
10. Javelaud D., Mohammad K.S., McKenna C.R., Fournier P., Luciani F., Niewolna M., Andre J., Delmas V., Larue L., Guise T.A., Mauviel A. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res. 2007, 67:2317-2324.
11. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
12. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2007, 57(2007):43-66.
13. Kan T., Sato F., Ito T., Matsumura N., David S., Cheng Y., Agarwal R., Paun B.C., Jin Z., Olaru A.V., Selaru F.M., Hamilton J.P., Yang J., Abraham J.M., Mori Y., Meltzer S.J. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136:1689-1700.
14. Kim S., Han J., Lee S.K., Koo M., Cho D.H., Bae S.Y., Choi M.Y., Kim J.S., Kim J.H., Choe J.H., Yang J.H., Nam S.J., Lee J.E. Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells. Cancer Lett. 2012, 314:147-154.
15. Kim Y.K., Yu J., Han T.S., Park S.Y., Namkoong B., Kim D.H., Hur K., Yoo M.W., Lee H.J., Yang H.K., Kim V.N. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009, 37:1672-1681.
16. Li Y., Tan W., Neo T.W., Aung M.O., Wasser S., Lim S.G., Tan T.M. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 2009, 100:1234-1242.
17. Papageorgis P., Lambert A.W., Ozturk S., Gao F., Pan H., Manne U., Alekseyev Y.O., Thiagalingam A., Abdolmaleky H.M., Lenburg M., Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 2010, 70:968-978.
18. Petrocca F., Vecchione A., Croce C.M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008, 68:8191-8194.
19. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., Bertrand E., Filipowicz W. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309:1573-1576.
20. Poliseno L., Salmena L., Riccardi L., Fornari A., Song M.S., Hobbs R.M., Sportoletti P., Varmeh S., Egia A., Fedele G., Rameh L., Loda M., Pandolfi P.P. Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal. 2010, 3:ra29.
21. Qiao Y., Ma N., Wang X., Hui Y., Li F., Xiang Y., Zhou J., Zou C., Jin J., Lv G., Jin H., Gao X. MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Lett. 2011, 585:3095-3100.
22. Razumilava N., Bronk S.F., Smoot R.L., Fingas C.D., Werneburg N.W., Roberts L.R., Mott J.L. MiR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 2011, 55:465-475.
23. Singh P., Wig J.D., Srinivasan R. The Smad family and its role in pancreatic cancer. Indian J. Cancer 2011, 48:351-360.
24. Smith A.L., Iwanaga R., Drasin D.J., Micalizzi D.S., Vartuli R.L., Tan A.C., Ford H.L. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling and induces EMT, and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012.
25. Tang Y., Liu Z., Zhao L., Clemens T.L., Cao X. Smad7 stabilizes β-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J. Biol. Chem. 2008, 283:23956-23963.
26. Wang X., Zhang X., Ren X.P., Chen J., Liu H., Yang J., Medvedovic M., Hu Z., Fan G.C. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010, 122:1308-1318.
27. Yan X., Chen Y.G. Smad7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling. Biochem. J. 2011, 434:1-10.
28. Yu X.F., Zou J., Bao Z.J., Dong J. MiR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J. Gastroenterol. 2011, 17:4711-4717.
29. Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.
30. Zou C., Zhang H., Li Q., Xiao H., Yu L., Ke S., Zhou L., Liu W., Wang W., Huang H., Ma N., Liu Q., Wang X., Zhao W., Zhou H., Gao X. Heme oxygenase-1: a molecular brake on hepatocellular carcinoma cell migration. Carcinogenesis 2011, 32:1840-1848.